M&A Deal Summary

Neuronetics Acquires Greenbrook TMS

On August 12, 2024, Neuronetics acquired healthcare services company Greenbrook TMS

Acquisition Highlights
  • This is Neuronetics’ 1st transaction in the Healthcare Services sector.
  • This is Neuronetics’ 1st transaction in Canada.
  • This is Neuronetics’ 1st transaction in Ontario.

M&A Deal Summary

Date 2024-08-12
Target Greenbrook TMS
Sector Healthcare Services
Buyer(s) Neuronetics
Deal Type Merger

Target

Greenbrook TMS

Toronto, Ontario, Canada
Greenbrook TMS is a provider of TMS Therapy, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook TMS was founded in 2011 and is based in Toronto, Ontario.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Neuronetics

Malvern, California, United States

Category Company
Sector Medical Products
DESCRIPTION

Neuronetics is a medical device company focused on developing non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses. Neuronetics is based in Malvern, California.


DEAL STATS #
Overall 1 of 1
Sector: Healthcare Services M&A 1 of 1
Type: Merger M&A Deals 1 of 1
State: Ontario M&A 1 of 1
Country: Canada M&A 1 of 1
Year: 2024 M&A 1 of 1